Pediatric patients†: Plasma half-life of 2.4 hours reported in a limited number of neonates 2–49 days of age† and infants and children 9 months to 12 years of age† receiving IV ganciclovir.StabilityStorageParenteralPowder for IV Infusion...
8metabolite stability, or mode of action of these two drugs.3Ganciclovir is available for systemic (intravenous or by mouth) and intravitreal administration in humans, where it is associated with greater toxicity than acyclovir. Toxicity is typically evident as bone marrow suppression. Very recently,...
Ganciclovir solutions (0.5% and 1.0%) prepared by diluting DENOSINE IV Infusion in saline were stored light-shielded at 4, 25, or 37掳C for 12 weeks. Every two weeks during storage, macroscopic evaluation was conducted and ganciclovir concentrations were determined by high performance liquid ...